Tag: Dr Kiran Mazumdar Shaw

The CHMP positive opinion will be considered by the European Commission whose decision on the approval is expected by the end of September 2023

73% of graduating students are females; 100% placement achieved

Overall Score of 66 puts Biocon in the 89th percentile in 2022 assessment

The company garnered the maximum number of votes from among 70,000 biopharma professionals who participated in the survey

The unit will boost of CAR-T Cell Therapy & Immunotherapy and has proficient medical staff including of haemato-oncologists, BMT physicians and nursing staff.

Gytree.com uses technology to provide women with an intelligent dashboard, world class experts and personalized journeys for better health outcomes.

Customers get access to distinctive services such as genetic tests, genetic counseling, blood tests, health screening tests, antibody tests and COVID-19 RT-PCR tests

Innovation, R&D, partnership & policy support to be key growth drivers as echoed at Global Innovation Summit-2021 organized by Indian Pharmaceutical Alliance

BBL will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets. SILS to receive ~15% stake in BBL at a post-money valuation of ~$4.9 billion......................

As per experts, the digital-enabled regulatory flexibility during the pandemic that had helped bring drugs faster to market needs to continue.....................